Details about the neuroanatomical projections from CA1 to PIR

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88650 Field CA1Piriform area moderatebiotinylated dextran amine (BDA)
Collator note: increase of the labeling of the PIR, caudally. The highest labeling in shown in Fig 4D, Swanson Atlas Levels 31-32, layer II.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88706 Field CA1Piriform area light/moderatebiotinylated dextran amine (BDA)
Collator note: labeling of the caudalmost part of the PIR, layer II. See Fig. 7D, Swanson Atlas Levels 31-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f

Further details associated to record number 88706:
Position of injection: ventro-caudal
Topological position of injection: is contained
Extension of injection outside: none
The injection was performed in: left hemisphere
Position of terminal field: caudal
Topological position of terminal field: is contained
Extension of terminal field outside: none
The terminal field was found: ipsilateral